FGF2 and lung adenocarcinoma: Inhibition of FGF2 or FGFR1 in a pemetrexed-resistant lung adenocarcinoma cell line resulted in downregulation of vimentin and Slug level, reversed EMT cell morphology, and partially restored sensitivity to pemetrexed [176].